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On 3 January the European Parlia-
ment adopted in second reading 
a Regulation to replace the cur-
rent legislation on plant protection 
products, based on a Commission 
proposal from 2006. The new legis-
lation will increase the protection of 
human health and the environment, 
will lead to a better protection of 
agricultural production and will ex-
tend and deepen the single market 
of plant protection products.
This is certainly a very good way for 
the European Parliament and the 
Council to start the New Year – by 
improving the protection of human 
health and of the environment, said 
the Commissioner Androulla Vassil-
iou.
The new Regulation will facilitate in-
novation by establishing clear crite-
ria for approval of substances. Rules 
are proposed to ensure an open and 
competitive market. The existing 
legislation is improved and simpli-
fied, in particular in terms of approv-
al procedures.
The new rules confirm the impor-
tance that the European Commission 
gives to a high level of protection of 
human health and the environment, 
while at the same time harmonise 
further the availability of plant pro-
tection products. Moreover, they 
intend to favour competition and 
reduce administrative burden for all 
stakeholders.
The text contains provisions on the 
following main issues:
criteria for approval of active sub-
stances; inspection and monitoring 
on production, storage, transport 
and use of plant protection prod-
ucts; a simplified evaluation and 
authorization procedure; the role of 
the European Food Safety Authority 
(EFSA); data protection – data shar-
ing; mutual recognition for plant 
protection products; informing on 
the use of plant protection products 
to neighbours; reduction of tests on 
vertebrates.
The Commission welcomes the work 
done by the European Parliament 
and the Council as all objectives tar-
geted by the initial proposal have 
been maintained in the text result-
ing from the co-decision process.
The new legislation has to be for-
mally adopted by the Council, and 
it will enter into force later this year. 
Together with the end of the review 
programme of existing active sub-
stances, the Commission will have 
met its objective to make sure that 
efficient plant protection is achieved 
with safer products.
For further information, please view:
http://europa.eu/rapid/pressReleasesAction.
do?reference=MEMO/09/8&format=HTML&aged=0&la-
nguage=EN&guiLanguage=fr
2Preventing infant accidents: EU stan-
dard for baby walkers adopted
A European safety standard for baby 
walkers, which will help to prevent many 
childhood accidents, has been published 
in the Official Journal on 3 January, fol-
lowing its formal adoption by the Euro-
pean Commission. 
Given the rising incidence of accidents 
caused by this equipment, Member States 
requested that a safety standard be set at 
EU level and backed the Commission’s 
proposal to introduce this standard at 
the General Product Safety Committee 
(GPSD) in November 2008 and the Euro-
pean Parliament has also welcomed the 
decision.
The EU standard introduces a require-
ment for stability tests during the manu-
facture of baby walkers, and for the de-
sign to be geared towards reducing the 
risk of injuries.
The standard will provide all economic 
operators and market surveillance au-
thorities will have a clear, quick and sin-
gle reference for making, importing or 
checking baby walkers for safety. Such 
standard was developed by the Europe-
an Committee for Standardisation (CEN), 
and is already being used by market sur-
veillance authorities in Member States 
when checking the market for unsafe 
childcare products.
Standards are voluntary, but a product 
manufactured according to a standard 
published in the EU Official Journal is pre-
sumed to be safe. If manufactures chose 
to deviate from the EU standard, they 
have to ensure that their product pro-
vides the same safety levels and require-
ments indicated in the standard. 
For further information, please see:
http://ec.europa.eu/consumers/safety/
news/index_en.htm
http://www.cen.eu/
In brief Cancer screening in Europe needs to be doubled
In the first Report on the Imple-
mentation of the Council Recom-
mendation of 2 December 2003 on 
cancer screening, published on 22 
January, the Commission highlights 
that although much progress has 
been made within the area of can-
cer screening, more is still required. 
By providing a clear description of 
the situation and the gaps, this re-
port helps to renew the commit-
ment to put in place breast, cervical 
and colorectal cancer screening as a 
crucial and cost-effective measure to 
reduce the burden of cancer in the 
European Union.
Cancer is the second most common 
cause of death in the European Un-
ion. Breast, cervical and colorectal 
cancer accounts for 32% of cancer 
deaths in women and % in men. 
With an ageing population, the fig-
ures are due to increase unless pre-
ventive measures are taken to re-
duce cancer deaths.
The EU shares a common commit-
ment to ensuring proper screening 
for breast, cervical and colorectal 
cancer, as set out in Council Recom-
mendation of 2 December 2003 on 
cancer screening (2003/878/EC).
In the first implementation report, 
published on 22 January, the Com-
mission highlights that although 
much progress has been made in the 
field of cancer screening, Member 
States have not fully put this screen-
ing in place. The current annual vol-
ume of screening examinations in 
the EU is considerable; however, this 
volume is less than one-half of the 
minimum annual number of exami-
nations that would be expected if 
the screening tests specified in the 
Council Recommendation on cancer 
screening were available to all EU 
citizens of appropriate age (approxi-
mately 25 million examinations per 
year). 
Less than half of these examinations 
(4%) are performed in population-
based programmes which provide 
the organisational framework for 
implementing comprehensive qual-
ity assurance as required by the 
Council Recommendation.
Also, less than half of the minimum 
recommended numbers of screen-
ings take place in the EU each year. 
Member States should continue 
to improve or implement popula-
tion-based cancer screening pro-
grammes, supported by collabora-
tion between Member States and 
professional, organisational and sci-
entific bodies and experts.
The Commission intends to form 
a European partnership for action 
against cancer in 2009  by bring-
ing together relevant stakeholders 
across the EU in a collective effort to 
addressing cancer. The partnership 
will support Member States in their 
efforts to tackle cancer more effec-
tively.  Key areas for future cancer ac-
tivities include: heath information, 
collection and analysis of compara-
ble data; primary prevention; iden-
tification and promotion of good 
practice in cancer-related health-
care; priorities for cancer research.
The Report on the Implementation of the Council 
Recommendation of 2 December 2003 on cancer 
screening is available at the following URL: 
http://ec.europa.eu/health/ph_determinants/genet-
ics/keydo_genetics_en.htm
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nesses take product safety seriously 
and respect the obligations placed 
on them by the Directive.
The report suggests a number of 
ways in which to develop the frame-
work and actions, including:
• the benefits which would be gained 
by further co-coordinated market 
surveillance between the Member 
States, given the increasingly global 
market and more and more products 
coming to the EU from third coun-
tries;
• the need to be able to better trace a 
dangerous product back to its manu-
facturer or importer in order to take 
fully effective measures;
• the scope to increase efficiency 
if the Commission, assisted by the 
Member States, were more quickly 
and easily able to ensure that there 
are state-of-the-art standards for in-
dividual products and, furthermore, 
when a risk is generally recognised, 
to ban the marketing of such a prod-
uct or substance permanently under 
this instrument rather than further 
product-specific directives.
The implementation report is not 
however an act whereby the Com-
mission puts forward any concrete 
proposals and further conclusions in 
this respect will follow later.
First Eurobarometer on mental health 
and children
Improving the mental health and well-
being of children and young people is 
one of the five priorities set out in the Eu-
ropean Pact for Mental Health and Well-
being which was launched at the EU high 
level conference in June 2008. 
A new Flash Eurobarometer survey pub-
lished on 3 January on the Mental Health 
and Well-being of Children and Young 
people examined parents’ perceptions of 
their child’s mental health and well-be-
ing in 27 European Countries. Approxi-
mately 2,750 randomly selected parents 
(including step-parents/guardians) were 
interviewed. Several aspects of the qual-
ity of life were assessed: i.e. child’s level 
of energy and fitness, depressive moods 
and emotions, stressful feelings, physical 
well-being, child’s autonomy, as well as 
child’s opportunities to structure and en-
joy his/her social life and leisure time and 
participation in social activities. 
The survey uses a standardised cross-cul-
tural assessment tool, the KIDSCREEN-
index. The results of the survey show 
wide variations both between and within 
countries. This survey tool complements 
existing health data on the mental and 
psychological well-being of children and 
young people in the monitoring of popu-
lation health.
For a short summary of the results:
http://ec.europa.eu/health/ph_determi-
nants/life_style/mental/mental_health_
en.htm
To read the complete results of the Flash 
Eurobarometer:
http://ec.europa.eu/public_opinion/in-
dex_en.htm
In briefGeneral Product Safety Directive: 
positive record 2004-2008
On 4 January the European Com-
mission adopted a Communication 
to the European Parliament and the 
Council, reporting on the first years 
(2004-2008) of implementation of 
the General Product Safety Directive. 
This is the basic legislation governing 
the safety of non-food consumer 
products in the EU. The Directive in 
essence sets out the Member States’ 
powers and duty to control the mar-
ket and take appropriate measures 
should unsafe products be found, 
and also sets out the corresponding 
duties of the economic operators.
The General Product Safety Direc-
tive has proven to be a powerful 
tool for ensuring a high level of con-
sumer protection and I am pleased 
to confirm once again that we are 
on the right track in making use of 
this Directive, which is one of the 
most important instruments in the 
consumer safety armoury, Commis-
sioner Meglena Kuneva said.
The Directive has laid down clear 
responsibilities to track down and 
eliminate unsafe products from the 
European market. The RAPEX sys-
tem, the European rapid alert system 
for dangerous non-food consumer 
products, set up under the Directive, 
has gained rapidly in efficiency and 
is a model or benchmark for many 
third countries or regions.
The major increase in RAPEX notifi-
cations over the last four years is a 
clear indication that market surveil-
lance under the Directive has been 
successful.
Furthermore, economic operators 
are increasingly adopting measures 
on their own initiative to contain the 
risks posed by consumer products. 
This shows that responsible busi-
For more information, please see:
http://ec.europa.eu/consumers/safety/prod_legis/in-
dex_en.htm
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Commission takes steps to 
promote patient safety in Europe
The Commission has recently adop-
ted a Communication and proposal 
for a Council Recommendation with 
specific actions that Member States 
can take, either individually, collec-
tively or with the Commission, to 
improve the safety of patients. Each 
year, in the EU, between 8% and 
2% of patients admitted to hospi-
tals suffer harm from the healthcare 
they receive, including from health-
care associated infections. Much of 
that harm is preventable.
The most common types of adverse 
events in healthcare are: healthcare 
associated infections; incorrect or 
delayed diagnoses; surgical errors; 
and medication related errors. Most 
efforts to improve patient safety at 
Member State and EU levels have so 
far focussed on specific causes, for 
example, minimising the risk from 
medicinal products, medical devices 
or antimicrobial resistance.
The Commission Communication 
recommends a comprehensive ap-
proach to improving patient safety. 
Member States are encouraged to 
put in place and improve strate-
gies to prevent and control adverse 
events in all healthcare settings. The 
primary focus is on addressing sys-
temic and organisational failures re-
sponsible for most harm to patients. 
Key recommendations for Member 
States include, for example: estab-
lishing or strengthening reporting 
and learning systems; embedding 
patient safety in the education and 
training of healthcare workers; in-
volving patients in the development 
of safety measures; and providing 
patients with relevant information 
on health risks and safety issues. 
Member States are also encouraged 
to share best practice and expertise 
in this field. 
For further information, please see:
http://ec.europa.eu/health/ph_systems/patient_safe-
ty_en.htm
Public consultation on Europe’s 
workforce for health
In the end of 2008 the European Com-
mission adopted a green paper on the 
EU workforce for health. This marked 
the beginning of a consultation period 
which aims to identify common re-
sponses to the many challenges facing 
the health workforce in Europe.
In ageing Europe, with growing health-
care costs and rising expectations from 
both citizens and patients, a high qual-
ity health workforce is crucial for suc-
cessful health systems. The health work-
force plays an important role in the EU 
economy accounting for about 0% of 
all jobs. In addition, 70% of EU health-
care budgets are allocated to salaries 
and employment related issues.
The ageing population is changing the 
pattern of disease and placing new 
and increasing demands on healthcare 
workers. It also means that the health 
workforce is itself an ageing one and 
there are insufficient new recruits to re-
place those that are retiring or leaving 
the EU. Migration of health profession-
als into and out of the EU and mobility 
within the EU also has impacts on the 
supply and distribution of health work-
ers. 
The aim of the green paper is to launch a 
debate on how best to tackle such chal-
lenges and to engage stakeholders in 
discussion.
The green paper is available at:
http://ec.europa.eu/health/ph_sys-
tems/workforce_en.htm
In brief
A pact for toy safety in the EU
In the end of 2008, European Con-
sumer Affairs Commissioner Megle-
na Kuneva signed an agreement 
with representatives of toy retailers 
and importers in a toy store near 
Brussels, as part of the Commission’s 
drive to improve toy safety by en-
gaging all actors throughout the toy 
industry. Formerly, the Commission 
signed a similar agreement with Toy 
Industries of Europe.
A product safety stocktaking exer-
cise carried out by the Commission 
at the end of 2007 (after a series of 
high-profile recalls), showed that 
while reputable businesses make 
significant efforts to ensure that their 
products are safe, dangerous goods, 
including toys, are still finding their 
way onto the EU market. This is 
mainly due to gaps at the lower end 
of the market, where safety proce-
dures are not as rigorously respected 
or adhered to as they should be. For 
this reason, it is crucial to have the 
commitment of EU retailers and im-
porters in pushing forward the toy 
safety agenda and carrying out the 
necessary safety actions at ground 
level.
The industry signatories agreed to 
a number of activities to further im-
prove toy safety, including provid-
ing education and training on safety 
standards, with a particular focus on 
the “lower end of the market” where 
the vast majority of non-compliant 
toys are found. Clear safety guide-
lines will be developed to ensure 
that products meet the required 
standards.
For further information, please see::
http://ec.europa.eu/consumers/citizen/my_safety/in-
dex_en.htm
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